High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Daida, Hiroyuki ^a   Takayama, Tadateru ^b   Hiro, Takafumi ^b   Yamagishi, Masakazu ^c   Hirayama, Atsushi ^b   Saito, Satoshi ^d   Yamaguchi, Tetsu ^e   Matsuzaki, Masunori ^f  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d Keiai Hospital   (Japan)

^e TORANOMON HOSPITAL   (Japan)

^f YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Coronary artery disease; HbA1c; Intravascular ultrasound; Rosuvastatin

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD GLUCOSE MONITORING; BLOOD VESSEL; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DRUG DOSE TITRATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAVASCULAR ULTRASOUND; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FLUOROBENZENES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; JAPAN; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; PYRIMIDINES; RISK ASSESSMENT; RISK FACTORS; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84866313782     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-87     Document Type: Article

References (37)

1. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 2009, 54(4):293-302. 10.1016/j.jacc.2009.04.033, 19608026.
2. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006, 295(13):1556-1565. 10.1001/jama.295.13.jpc60002, 16533939.
3. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004, 291(9):1071-1080. 10.1001/jama.291.9.1071, 14996776.
4. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, Daida H. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 2004, 110(9):1061-1068. 10.1161/01.CIR.0000140261.58966.A4, 15326073.
5. Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, Yamaguchi T, Matsuzaki M. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J 2009, 73(11):2110-2117. 10.1253/circj.CJ-09-0358, 19801853.
6. Takayama T, Hiro T, Yamagishi M, Daida H, Saito S, Yamaguchi T, Matsuzaki M. Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in Japanese subjects: COSMOS study (Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects). Circ J 2007, 71(2):271-275. 10.1253/circj.71.271, 17251680.
7. Kojima T, Miyauchi K, Yokoyama T, Yokoyama K, Kurata T, Suwa S, Kawamura M, Tamura H, Okazaki S, Inoue K, et al. Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo University (ALPS-J). Circ J 2011, 75(5):1071-1079. 10.1253/circj.CJ-11-0141, 21471671.
8. Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochelliere R, Staniloae CS, Mavromatis K, et al. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA 2008, 299(13):1561-1573. 10.1001/jama.299.13.1561, 18378631.
9. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004, 292(18):2217-2225. 10.1001/jama.292.18.2217, 15536108.
10. Sipahi I, Tuzcu EM, Wolski KE, Nicholls SJ, Schoenhagen P, Hu B, Balog C, Shishehbor M, Magyar WA, Crowe TD, et al. Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials. Ann Intern Med 2007, 147(1):10-18.
11. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, et al. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome-serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). Circ J 2010, 74(6):1165-1174. 10.1253/circj.CJ-09-0766, 20467151.
12. Bayturan O, Kapadia S, Nicholls SJ, Tuzcu EM, Shao M, Uno K, Shreevatsa A, Lavoie AJ, Wolski K, Schoenhagen P, et al. Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. J Am Coll Cardiol 2010, 55(24):2736-2742. 10.1016/j.jacc.2010.01.050, 20538166.
13. Bonora E, Kiechl S, Mayr A, Zoppini G, Targher G, Bonadonna RC, Willeit J. High-normal HbA1c is a strong predictor of type 2 diabetes in the general population. Diabetes Care 2011, 34(4):1038-1040. 10.2337/dc10-1180, 3064019, 21307378.
14. Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Svensson AM, Gudbjornsdottir S, Eliasson B. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med 2010, 268(5):471-482. 10.1111/j.1365-2796.2010.02265.x, 20804517.
15. Elley CR, Kenealy T, Robinson E, Drury PL. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study. Diabet Med 2008, 25(11):1295-1301.
16. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001, 37(5):1478-1492. 10.1016/S0735-1097(01)01175-5, 11300468.
17. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, , et al. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes M Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Journal of Diabetes Investigation 2010, 1(5):212-228. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes M.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
19. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(Suppl 1):S62-69. 3006051, 21193628, American Diabetes Association.
20. Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 2008, 52(4):255-262. 10.1016/j.jacc.2008.03.051, 18634979.
21. Berry C, Noble S, Gregoire JC, Ibrahim R, Levesquie S, Lavoie MA, L'Allier PL, Tardif JC. Glycaemic status influences the nature and severity of coronary artery disease. Diabetologia 2010, 53(4):652-658. 10.1007/s00125-009-1651-x, 20225394.
22. Jandeleit-Dahm K, Cooper ME. The role of AGEs in cardiovascular disease. Curr Pharm Des 2008, 14(10):979-986. 10.2174/138161208784139684, 18473849.
23. Walcher D, Marx N. Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis. Semin Immunopathol 2009, 31(1):103-111. 10.1007/s00281-009-0144-9, 19347338.
24. Nasu K, Tsuchikane E, Katoh O, Fujita H, Surmely JF, Ehara M, Kinoshita Y, Tanaka N, Matsubara T, Asakura Y, et al. Plaque characterisation by Virtual Histology intravascular ultrasound analysis in patients with type 2 diabetes. Heart 2008, 94(4):429-433.
25. Sano K, Kawasaki M, Okubo M, Yokoyama H, Ito Y, Murata I, Kawai T, Tsuchiya K, Nishigaki K, Takemura G, et al. In vivo quantitative tissue characterization of angiographically normal coronary lesions and the relation with risk factors: a study using integrated backscatter intravascular ultrasound. Circ J 2005, 69(5):543-549. 10.1253/circj.69.543, 15849440.
26. Parathath S, Grauer L, Huang LS, Sanson M, Distel E, Goldberg IJ, Fisher EA. Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes 2011, 60(6):1759-1769. 10.2337/db10-0778, 3114401, 21562077.
27. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009, 373(9677):1765-1772. 10.1016/S0140-6736(09)60697-8, 19465231.
28. Jimenez-Quevedo P, Suzuki N, Corros C, Ferrer C, Angiolillo DJ, Alfonso F, Hernandez-Antolin R, Banuelos C, Escaned J, Fernandez C, et al. Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysis. Diabetes 2009, 58(1):209-214. 10.2337/db08-0376, 2606874, 18829988.
29. Reddy HK, Koshy SK, Foerst J, Sturek M. Remodeling of coronary arteries in diabetic patients-an intravascular ultrasound study. Echocardiography 2004, 21(2):139-144. 10.1111/j.0742-2822.2004.03014.x, 14961792.
30. Chhatriwalla AK, Nicholls SJ, Wang TH, Wolski K, Sipahi I, Crowe T, Schoenhagen P, Kapadia S, Tuzcu EM, Nissen SE. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. J Am Coll Cardiol 2009, 53(13):1110-1115. 10.1016/j.jacc.2008.09.065, 19324254.
31. Koh KK, Quon MJ, Sakuma I, Han SH, Choi H. Lee K 2011, Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients. Int J Cardiol, Shin EK.
32. Kostapanos MS, Milionis HJ, Agouridis AD, Rizos CV, Elisaf MS. Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose. Int J Clin Pract 2009, 63(9):1308-1313. 10.1111/j.1742-1241.2009.02101.x, 19691613.
33. Moutzouri E, Liberopoulos E, Mikhailidis DP, Kostapanos MS, Kei AA, Milionis H, Elisaf M. Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance. Int J Clin Pract 2011, 11:1141-1148.
34. Anagnostis P, Selalmatzidou D, Polyzos SA, Panagiotou A, Slavakis A, Panagiotidou A, Athyros VG, Karagiannis A, Mikhailidis DP, Kita M. Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study. Int J Clin Pract 2011, 65(6):679-683. 10.1111/j.1742-1241.2011.02655.x, 21564441.
35. Bellia A, Rizza S, Galli A, Fabiano R, Donadel G, Lombardo MF, Cardillo C, Sbraccia P, Tesauro M, Lauro D. Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes. Atherosclerosis 2010, 210(1):199-201. 10.1016/j.atherosclerosis.2009.11.021, 20018286.
36. Lamendola C, Abbasi F, Chu JW, Hutchinson H, Cain V, Leary E, McLaughlin T, Stein E, Reaven G. Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia. Am J Cardiol 2005, 95(2):189-193. 10.1016/j.amjcard.2004.09.005, 15642550.
37. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2011, 10:103. 10.1186/1475-2840-10-103, 3235986, 22108456.